Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharma Snubs WHO Call To Pool COVID-19 Patents

WHO Says Initiative Aims To Ensure Equitable Access

Executive Summary

Almost three dozen countries have shown support for the alternative mechanism put forward by the World Health Organization to ensure that IP issues do not stand in the way of providing access to COVID-19 medicines, vaccines and diagnostics to ‘all of humanity.’

You may also be interested in...



EU Urges Free Access To Publicly Funded COVID-19 Research Results

A “manifesto” to encourage the wider dissemination of COVID-19 research is the latest in a series of EU and international initiatives to quickly find treatments, vaccines and tests for the coronavirus. 

Coronavirus Update: More Drugs Enter Trials, UK To Host Latest Vaccine Summit

In addition to our daily in-depth coverage of key events relating to the coronavirus, we’re bringing you a periodic round-up of other pandemic developments. This edition covers events at the national, European and global level. 

WHO ‘Showed Leadership’ In Dealing With COVID-19, Says Interim Inquiry

An interim independent assessment of the WHO’s response to the COVID-19 pandemic has supported the organization’s work. But will be it enough to convince critics as the WHO faces the threat of permanently losing funds from its biggest donor, the US?

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS142279

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel